Institute of Addiction Medicine

The Institute of Addiction Medicine (IAM) is a clinical research and education organization based in Plymouth Meeting, Pennsylvania, dedicated to advancing evidence-based treatments for substance use disorders. Founded by Dr. Joseph Volpicelli, a pioneer in the use of naltrexone for alcohol addiction, the institute bridges the gap between scientific research and clinical practice. IAM conducts clinical trials for pharmacological interventions and digital therapeutics, such as the MODIA program for opioid use disorder, and provides specialized training for healthcare professionals. The organization also advocates for the integration of medication-assisted treatment with psychosocial support to improve patient outcomes in addiction recovery.